Solid Tumors clinical trials
Showing 1,101–1,133 of 1,133 active trials. Describe your situation to see which ones look like a fit.
- A Study of Raludotatug Deruxtecan in Participants With Advanced/Metastatic Solid Tumors (REJOICE-PanTumor01)
- Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)
- A Study of NTX-1088, a Monoclonal Antibody Targeting the Poliovirus Receptor (PVR, CD155), as Monotherapy and Combined With Pembrolizumab
- Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors
- A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors
- Study of LP-184 in Patients With Advanced Solid Tumors
- A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours
- A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors
- S095035 as a Single Agent and in Combination in Adult Participants With Advanced or Metastatic Solid Tumors With Deletion of MTAP
- A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors
- A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours
- Chiauranib for Advanced Solid Malignant Tumors and Relapsed/Refractory SCLC.
- Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors
- Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies
- A Study of Valemetostat Tosylate in Combination With DXd ADCs in Subjects With Solid Tumors
- Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers
- T-regulatory Cell Depletion with E7777 Combined with Pembrolizumab in Recurrent or Metastatic Solid Tumors
- A Study of Avutometinib for People With Solid Tumor Cancers
- Study Assessing MTD, Safety, Tolerability, PK and Anti-tumor Effects of LNS8801alone and With Pembrolizumab
- Study of INCB123667 in Subjects With Advanced Solid Tumors
- Study for AZD4360 in Participants With Advanced Solid Tumours
- Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)
- Phase 2b Imaging Study of RAD101 in Participants With Suspected Recurrent Brain Metastases
- Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
- 18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- Symptom Burden and Health Related Quality of Life of Cancer Patients With Concurrent Heart Failure
- Futibatinib in Patients Previously Enrolled in an Antecedent Futibatinib as Monotherapy or Combination Therapy.
- Characterizing Sleep Among Long-term Survivors of Childhood Cancer
- Improving Cancer-related Fatigue, Sexual Dysfunction and Quality of Life in Older Men With Cancer and Androgen Deficiency
- Exploring Mindsets, Beliefs and Resilience Across the Cancer Experience
- Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies
- DISCO: A Patient Intervention to Reduce the Financial Burden of Cancer
- Health Benefits of Writing Therapy Among Asian American Cancer Survivors
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.